ISSC:NASDAQInnovative Solutions and Support, Inc. Analysis
Data as of 2026-07-10 - not real-time
$18.85
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Innovative Aerosystems is trading at $18.85, just above its 20‑day SMA of 17.78 and the 200‑day SMA of 17.73, while the RSI sits at a neutral 57 and the MACD shows a bullish histogram. Volume is on an increasing trend, supporting the recent price lift, and the stock sits comfortably above the identified support of 15.98 with resistance near 19.45. Fundamentals reveal robust profitability – a gross margin of 50.7%, operating margin of 25.7% and ROE of 27% – yet the balance sheet is leveraged, with a debt‑to‑equity ratio above 76% and net cash negative. Valuation metrics are mixed: the trailing P/E of 19.8 is well below the industry average of 31.2, suggesting relative cheapness, but the DCF fair value of $4.35 signals significant overpricing relative to intrinsic estimates. Analyst consensus targets around $27‑$28 imply a potential upside of roughly 50%, aligning with the current “Extreme Greed” sentiment on the fear‑greed index. High beta (computed ~2.44) and 30‑day volatility exceeding 60% amplify short‑term risk, while the lack of dividend payout removes any income cushion. In summary, the stock presents a blend of attractive margins and upside potential tempered by leverage, volatility, and valuation divergence.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram supporting near‑term price stability
- Price trading above short‑term moving averages
- Elevated volatility and high beta increasing downside risk
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst price targets indicating ~50% upside
- Strong profitability metrics (gross margin >50%, ROE 27%)
- Valuation multiple below industry average despite leverage
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Durable defense and aerospace contracts providing secular demand
- Consistent operating cash flow and free cash flow generation
- High return on equity suggesting effective capital deployment
Key Metrics & Analysis
Financial Health
Revenue Growth2.00%
Profit Margin18.82%
P/E Ratio19.8
ROE27.14%
ROA12.97%
Debt/Equity76.16
P/B Ratio4.7
Op. Cash Flow$20.6M
Free Cash Flow$8.8M
Industry P/E31.2
Technical Analysis
TrendNeutral
RSI57.0
Support$15.98
Resistance$19.45
MA 20$17.78
MA 50$18.15
MA 200$17.73
MACDBullish
VolumeIncreasing
Fear & Greed Index94.59
Valuation
Fair Value$4.35
Target Price$28.25
Upside/Downside49.87%
GradeFair
TypeBlend
Risk Assessment
Beta2.44
Volatility61.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.